Theodore Klumpp (standing) leads a meeting at FDA.   He left FDA in 1941 for the American Medical Association and two years later became the president of Winthrop-Stearns.

Three months after the President signed the 1938 Act, Theodore Klumpp, who received his medical training at Harvard and served on the faculty at Yale University, assumed leadership of the Drug Division after Durrett resigned. By this time, the Division consisted of a Chemical Section, a Collaboration Section, a Medical Section, and a Veterinary Section, and most of the work focused on reviewing NDAs. Within the first year of this requirement, the Division received over 1200 applications.